The impact of the National Health Insurance Scheme on medication adherence of hypertensive patients
Main Article Content
Abstract
Background: There is paucity of information on the effectiveness of the National Health Insurance Scheme (NHIS) in improving medication access in hypertensive patients, as well as its impact on adherence rates and patient outcomes.
Objectives: This study investigated the impact of NHIS enrollment on medication adherence in hypertensive patients by assessing disparities in adherence profiles and patterns of barriers to medication adherence between enrolled and non-enrolled patients of the NHIS, and evaluating the extent to which cost of medication affects adherence.
Methods: The study was conducted as a cross-sectional prospective study. Medication adherence score was determined using the eight-item Morisky Medication Adherence Scale, which was self-administered to 250 selected patients on NHIS and non-NHIS respectively. Data was analyzed using SPSS 16 for Windows (Chicago, IL); Mean ± standard deviation was computed for continuous data, Mean values were compared using t-test while comparisons of proportions were carried out using Chi square. All hypotheses tested were two tailed, with significance at p < 0.05.
Results: The mean adherence score for the NHIS group was 4.40 ± 2.28, while respondents in the non-NHIS grouprecorded a mean adherence score of 4.92 ± 2.15. The non-NHIS group reported a statistically significant higher adherence score (p= 0.011). From the multiple linear regressions, there was a positive correlation between adherence score and age and duration of disease. There was also statistically significant negative correlation between adherence scores and educational level, monthly income, and improving health status.
Conclusion: Enrollment in the NHIS was not associated with better medication adherence level despite associated lower cost of medication. Cost of medication was not found to be a statistically significant barrier to adherence in this study.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
Share
References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005). Global burden of hypertension: Analysis of worldwide data. Lancet.
:217-223.
Boima V, Ademola AD, Odusola AO, Agyekum F, Nwafor CE, Cole H, Salako BL, Ogedegbe G, Tayo BO. (2015). Factors Associated with Medication Nonadherence among Hypertensives in Ghana and Nigeria. International Journal Hypertens. 2015:205716.
Sabate E (2003). World Health Organization. Adherence to Long Term Therapies: Evidence for action. Geneva: World Health Organization.
Dunbar Jacob J, Erlen JA, Schlenk EA (2000). Adherence in chronic disease. Annu Rev Nurs Res; 18: 48 90. 160 West African Journal of Pharmacy (2023) 34 (2) 5.
Osterberg L, Blaschke T (2005). Adherence to medication. N Engl Journal Med Aug 4;353 (5): 487- 497
Fadare J, Olamoyegun M, Gbadegesin BA. (2015). Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi Med Journal 27:65-70.
Carrin G, Evans D, Xu K (2007). Designing health financing policy towards universal coverage. Bull World Health Organ 85:652
Gottret P, Schieber G (2006). Health Financing Revisited: A Practioner’s Guide. Washington DC: The International Bank for Reconstruction and Development/The World Bank.
Drechsler D, Jütting J (2005). Private Health Insurance in Low and Middle-Income Countries: Scope, Limitations, and Policy Responses. Issy-les Moulineaux: OECD Development Centre.
World Health Organization (2005). Designing health financing systems to reduce catastrophic health expenditure. Technical briefs for policy makers. 2 :1- 4.
National Health Insurance scheme. [Online]. Available from: http://www.nhis.gov.ng/.National Health Insurance scheme. NHIS Programs.
[Online]. Available from: http://www.nhis.gov.ng/index.php option=com_contentandview=articleandid=53andI temid=57 [Accessed 2011 Jun 10].
Palmer N, Mueller DH, Gilson L, Mills A, Haines A (2004). Health financing to promote access in low income settings - How much do we know? Lancet 364:1365 -1370.
Lange JM, Schellekens OP, Lindner M, van der Gaag J (2008). Public private partnerships and new models of healthcare access. Curr Opin HIV AIDS. 3 :509 - 513.
Kannegiesser L. National Health Insurance Scheme to boost generics market in Nigeria. [Online]. Available from:
http://www.frost.com/prod/servlet/marketinsighttop.pag Src=RSSanddocid=155485216. [Accessed 2011 Jun 11]
Olakunde BO (2012). Public health care financing in Nigeria: Which way forward? Ann Nigerian Med 6:4- 10
World Bank (2008). World Bank - Administered Groba Launches Pre-paid Health Insurance Scheme in Lagos Nigeria. [Online]. Available from: http://web.worldbank.org/....pagePK:2865066~piP K:2865079~theSitePK:368896,00.html. [Accessed 2011 Jun 19].
Ogbonnaya R. NHIS-Meeting Health Challenges Amidst Obstacles. Thisday. 4th January 2010. [Online]. Available
from:http://allafrica.com/stories/201001250876.html?page=2.
Ibiwoye A, Adeleke IA (2008). Does National Health Insurance Promote Access to Quality Health Care? Evidence from Nigeria. The Geneva Papers 33:219- 233
Sanusi RA, Awe AT (2009). Perception of National Health Insurance Scheme (NHIS) by Healthcare consumers in Oyo State, Nigeria. Pak Journal Soc Sci 6:48-53.
Agba AM, Ushie EM, Osuchukwu NC (2010). National Health Insurance Scheme (NHIS) and Employees? Access to Healthcare Services in Cross River State, Nigeria. Global Journal Hum Soc Sci 10:9- 16.
Mohammed S, Sambo MN, Dong H (2011). Understanding client satisfaction with a health insurance scheme in Nigeria: Factors and enrollees experiences. Health Res Policy Syst 9:20
De Allegri M, Sauerborn R, Kouyate B, Flessa S (2009). Community health insurance in sub Saharan Africa: what operational difficulties hamper its successful development? Trop Med International Health. 14 :586-596.
Amira CO, Okubadejo NU (2007). Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians. Niger Postgrad Med Journal Dec;14(4):325-329.
Rosner, B. (2011) Chapter 7: Hypothesis Testing: Categorical Data/Estimation of Sample Size and Power for Comparing Two Binomial Proportions. Fundamentals of Biostatistics, 7th Edition, Brooks/Cole, Boston.
Morisky DE, Ang A, Krousel-Wood MA (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal Clin
Hypertens. 10:348-354.
Krousel-Wood M, Islam T, Webber LS (2009). New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am Journal Manag Care. 15:59-66.
Zyczynski TM, Coyne KS (2000). Hypertension and current issues in compliance and patient outcomes. Curr Hypertens Rep. 2:510 - 514
Wetzels GE, Nelemans P, Schouten JS, Prins MH (2004). Facts and fiction of poor compliance as a 161 West African Journal of Pharmacy (2023) 34 (2) cause of inadequate blood pressure control: a systematic review. Journal Hypertens. 22(10):1849- 1855.
Dennison CR, Peer N, Steyn K, Levitt NS, Hill MN (2007). Determinants of hypertension care and control among peri-urban Black South Africans: The HiHi study. Ethn Dis. 17:484-491.
Akintunde A A, Akintunde TS(2015). Antihypertensive Medications Adherence Among Nigerian Hypertensive Subjects in a Specialist Clinic
Compared to a General Outpatient Clinic. Ann Med Health Sci Res. 5(3): 173 -178.
Benson J, Britten N (2002). Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. Br Med Journal 325:873.
Gascón JJ, Sánchez-Ortuño M, Llor B, Skidmore D, Saturno PJ (2004). Treatment Compliance in Hypertension Study Group; Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 21:125 - 130.
Familoni BO, Ogun SA, Aina AO (2004). Knowledge and awareness of hypertension among patients with systemic hypertension. JAMA. 96:620 - 624.
Osamor P.E, Owumi, B.E (2011). Factors Associated with Treatment Compliance in Hypertension in Southwest Nigeria Journal Health Popul Nutr. Dec; 29(6): 619 - 628.
Natarajan N, Putnam W, Van Aarsen K, Lawson K.B., Burge F (2013). Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician. 59(2): e93 - e100.
Gascón JJ, Sánchez-Ortuño M, Llor B, Skidmore D, Saturno PJ (2004). Treatment Compliance in Hypertension Study Group; Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 21:125 - 130.
Vawter L, Tong X, Gemilyan M, Yoon PW (2005). Barriers to antihypertensive medication adherence among adults-United States. Journal Clin Hypertens (Greenwhich) 10(12):922 - 929
Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC (2013). Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS One. 8:e62775.
Mukora-Mutseyekwa FN, Chadambuka EM (2013). Drug adherence behavior among hypertensive out- patients at a tertiary health institution in Manicaland province, Zimbabwe, 2011. Patient Prefer Adherence. 7:65 -70.
Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD (2006). Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 26(4):483 - 492.
Nelson MR, Reid CM, Ryan P, Willson K, Yelland L (2006). Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2) Med Journal Aust. 185(9):487 - 489.
Hyre AD, Krousel-Wood MA, Muntner P, Kawasaki L, 162 West African Journal of Pharmacy (2023) 34 (2) DeSalvo KB (2007). Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. Journal Clin Hypertens (Greenwich), 9: 179 -186
Isezuo AS, Opera TC (2000). Hypertension awareness among Nigerians in a Nigerian tertiary health institution. Sehel Med Journal 3:93 - 96.
Salako, BL, Ajose FA, Lawani E. (2003). Blood pressure control in a population where antihypertensives are given free. East African Med Journal vol. 80, no. 10, pp. 529-531